1. Medtech Insight
  3. >>North America

Senate Draft Chronic-Care Bill Seeks To Expand Telehealth Opportunities

 
• By Sue Darcey

The US Senate Finance Committee circulated a discussion draft of a chronic-care bill Oct. 27 that would promote telehealth and home-use devices. The bill would allow reimbursement for providers to use technology to monitor patients with chronic diseases through telehealth options in Medicare Advantage plans and accountable-care organizations.

A chronic-care discussion draft bill released by the US Senate Finance Committee Oct. 27 calls for providers to be reimbursed for services and technologies they provide to all Medicare Advantage patients who are homebound, beyond Part B payments now limited to telehealth services for patients residing in remote areas.

In addition, the proposed legislation would allow accountable care organizations (ACOs) to expand use of telehealth to chronic-care patients who find it difficult to meet their doctors at face-to-face office visits by providing payments to caretakers who

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from United States

More from North America

Switzerland Investigates Private Sector Assessment of FDA-Approved Medical Devices

 
• By Amanda Maxwell

Its move comes as the Swiss recognize the need to ensure adequate supplies on medical devices in its country.

New Guidance From Canada’s HTA Agency On Submission Of AI-Driven Evidence

 
• By Neena Brizmohun

Recognizing that the evidence it receives in applications for health technology assessments will increasingly be informed by artificial intelligence, the CDA-AMC has clarified its expectations for companies that use AI methods in the generation and/or reporting of evidence.

Medtronic Presents Data To Boost Hugo’s Odds Of Getting FDA Nod

 
• By Brian Bossetta

Medtronic says results from a recent study on the Hugo robotic-assisted surgery system substantiate its safety and effectiveness for various urological procedures. The company also announced it has submitted the system to the FDA for approval for a urological indication.